Please login to the form below

Not currently logged in
Email:
Password:

Clarivate Analytics

This page shows the latest Clarivate Analytics news and features for those working in and with pharma, biotech and healthcare.

Centre for Innovation in Regulatory Science awarded $1.09m Gates Foundation grant

Centre for Innovation in Regulatory Science awarded $1.09m Gates Foundation grant

CIRS is a neutral, independent UK-based subsidiary of Clarivate Analytics, which aims to maintain a leadership role in identifying and applying scientific principles for the purpose of advancing regulatory and

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Cortellis Drugs to Watch in 2020 report Cortellis Drugs to Watch in 2020 report

    Since 2013, the Cortellis Forecast team at Clarivate has applied its proprietary technologies, tools and techniques trusted by its global life sciences customers to produce the Drugs to Watch list, which ... Joan Tur is Cortellis Editor (Forecast Drugs)

  • The changing nature of approvals – what does the future hold? The changing nature of approvals – what does the future hold?

    The 2019 CMR International Pharmaceutical R&D Factbook. Clarivate Analytics, through its Centre for Medicines Research (CMR) International group, recently released the 2019 CMR International Pharmaceutical R&D Factbook –providing insights

  • Pharmaceutical innovation in the APAC region Pharmaceutical innovation in the APAC region

    The full report is free to download and is available from Clarivate Analytics.

  • Encouraging signs in biomarker R&D Encouraging signs in biomarker R&D

    Sarah Hardison, therapeutic area director from Clarivate Analytics, has also seen an industry response. ... Clarivate Analytics’ Sarah Hardison also acknowledged that industry may focus on cancers with biomarkers, but sees such an approach as an

  • The trials and tribulations of rare opportunities The trials and tribulations of rare opportunities

    Rare disease drugs can also generate high revenues, said Garth Ringheim, Therapeutic Area Director, Clarivate Analytics. ... In other instances where data is available for a large number of patient journeys with the rare disease of interest, predictive

More from intelligence
Approximately 1 fully matching, plus 5 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
BOLDSCIENCE

We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...

Latest intelligence

DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...

Infographics